The invention includes a skin treatment compound containing aloe vera and methods of use thereof. In one embodiment, the skin treatment compound includes aloe vera, and preferably 30×, 100× or 200× concentrated aloe vera powder, water, a Carbomer such as Ultrez powder, glycerin, lubricating ingredients, sodium hydroxide, Vitamin C, a complex mixture of skin-healing botanicals, Japanese Green Tea Extract, at least one amino acid precursor, a ceramide compound, an antioxidant, a glycosaminoglycan, and a natural preservative, preferably selected from the group consisting of lime oil, orange oil, and bergamot oil.

The present technology generally relates to compositions comprising cannabidiol (CBD) or a derivative thereof and at least one active cosmetic ingredient, for use in cosmetics and personal care products such as anti-aging or moisturizing creams for skin care and massage oils for muscle therapy.

Solid solution of gum arabic and at least one liposoluble active ingredient having particles of a size of less than 100 .Math.m and a weight ratio of gum arabic to liposoluble active ingredients of 5:1 to 200:1, obtainable by drying an aqueous solution of gum arabic to achieve a fine-particle dry product; admixing the dry product with a solution or dispersion of the liposoluble active ingredient(s) in an anhydrous solvent in which gum arabic is insoluble; mixing in the solution while homogenizing and further comminuting the dry product to a particle size of less than 100 .Math.m; and removing the solvent at a temperature of less than 70° C., as well as method for the preparation of the solution and the aqueous suspension containing it.

The invention relates to an anhydrous cosmetic or dermatological formulation comprising a viscose lipid-containing preparation and propellant gas consisting essentially of one or more substances selected from hydrofluorocarbons, n-butane, isobutane and propane. The formulation permits application to the skin by spraying of an otherwise nonsprayable preparation. The formulation is free from readily volatile solvents, surfactants, and preferably free from silicones.

Oral care compositions that have hops beta acid, such as from an extract from a species in the Humulus family, and a metal ion source, such as a tin ion source and/or a zinc ion source. Oral care compositions that have a tin ion source and/or a zinc ion source and one or more hops beta acids, such as from an extract from Humulus lupulus. Oral care compositions have a tin ion source and/or a zinc ion source and a beta acid derived from an extract of Humulus lupulus.

The present invention relates to an anhydrous composition for dyeing human keratin fibers, comprising at least one natural dye, at least one hydrazono and/or azo cationic synthetic direct dye and at least one compound of formula (I) in which Y represents a C.sub.1-C.sub.4 hydroxyalkyl group or a C.sub.1-C.sub.4 hydroxyalkyloxy radical, n denotes an integer ranging from 0 to 5, and X, which may be identical or different, represents a C.sub.1-C.sub.4 alkyl radical or a halogen. The invention also relates to a process for dyeing human keratin fibers using this composition.

##STR00001##

The invention relates to a composition comprising melatonin, a metabolite or derivative thereof and coenzyme Q10 and to use thereof for the production of a pharmaceutical or cosmetic composition for the treatment of the skin, said composition potentiating the movement of both molecules into the mitochondrion and facilitating percutaneous absorption, in which both the melatonin and the CoQ10 can reach all of the strata of the skin.

The embodiments relate to improved skin quality, health and appearance using a new delivery method and certain bioactive compositions and formulations. The system incorporates microneedle delivery technology with unique compositions and formulations. Such development allows for the pursuit of personalized medicine, or treatment delivery that can expand to remote controlled environment, immediate compounding and ultimate personalization with a state of the art longitudinal data predictive analytics. Certain formulations described herein are unique, combinatory and synergistic. Secured by high-tech proprietary system, there are unlimited potentials using AQT technology including but not limited to 3-D printing of a biodegradable micro chips that can be delivered via injection, AQT or any other possible route.

The present disclosure relates to semi-permanent inks (e.g., semi-permanent inks comprising genipin, a genipin derivative, lawsone, a lawsone derivative, or combinations thereof); semi-permanent ink applicators; transfer mediums; silicone adhesives; and silicone mediums and kits containing two or more of thereof. The present disclosure also relates to methods for applying an ink to skin as well as methods for increasing the darkness of a semi-permanent tattoo and/or increasing the longevity of a semi-permanent tattoo.

Compositions and methods are disclosed herein for inducing (up-regulating) the expression of sulfotransferases in the hair follicles, e.g., the scalp. Increasing sulfotransferase is beneficial for metabolizing pro-drugs that require sulfonation to be activated, e.g., minoxidil sulfate is the active metabolite of minoxidil. A method for combining the compositions described herein with topical minoxidil to enhance minoxidil treatment for androgenetic alopecia is described. Additional methods and compositions include the use of retinoid X receptor agonists, retinoic acid receptor agonists, and nuclear receptor agonists in an RXR—NR heterodimer. Additional methods and compositions include the use of a topical solution containing an alkalinizing agent or an alkalinizing agent used with a penetration enhancer for up-regulating the sulfonating capacity of hair bearing skin, hair follicles, and/or keratinocyte cells. In addition, compositions and methods for increasing or decreasing the growth rate of hair follicles is disclosed by altering the intracellular pH.